Gabapentin detection in drug screening
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin Detection in Drug Screening: Analytical Methods and Clinical Relevance
High-Throughput and Mass Spectrometry-Based Detection of Gabapentin
Modern drug screening for gabapentin relies heavily on advanced analytical techniques. Liquid chromatography coupled with mass spectrometry (LC-MS/MS and LC-TOF-MS) enables both high-throughput screening and precise quantification of gabapentin in blood, with detection limits as low as 0.1 mg/L. These methods are reliable for both clinical and forensic applications, confirming all positive cases and ensuring no false negatives in negative screens. This approach is particularly useful for investigating drug-impaired driving, drug-facilitated crimes, and post-mortem toxicology .
Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) is also validated for gabapentin detection in human plasma, offering high sensitivity (LOD of 13.37 ng/mL) and a strong green chemistry profile, making it suitable for pharmacokinetic and bioequivalence studies .
Gas Chromatography and Solid-Phase Extraction
Gas chromatography-mass spectrometry (GC-MS) following solid-phase extraction and derivatization is another established method for gabapentin detection in serum and plasma. This technique achieves a detection limit of 0.1 µg/mL and is reliable for routine therapeutic drug monitoring, providing clean chromatograms and consistent results over extended periods .
Spectrofluorimetric and Spectrophotometric Approaches
Several studies have developed sensitive and cost-effective spectrofluorimetric and spectrophotometric methods for gabapentin detection. Fluorimetric protocols using derivatization with o-phthalaldehyde or nitrogen-doped carbon quantum dots (N-CQDs) offer high sensitivity, with detection limits in the low nanogram per milliliter range. These methods are validated for use in pharmaceutical quality control and spiked plasma samples, and the N-CQDs approach is noted for its eco-friendly design Attia2019Almalki2024.
Spectrophotometric methods based on Schiff base formation with salicylaldehyde provide a simple and economic alternative, with detection limits suitable for routine analysis in pharmaceutical preparations .
Nuclear Magnetic Resonance (NMR) for Non-Chromophoric Gabapentin
Quantitative NMR (qNMR) offers a direct and validated method for gabapentin determination in bulk drugs and formulations, bypassing the need for derivatization. This method is highly precise and robust, with detection limits around 0.025 mg/mL, making it a straightforward option for absolute quantification .
Electrochemical and Biosensor Technologies
Emerging biosensor technologies, such as DNA-based electrochemical sensors, provide rapid, selective, and low-cost detection of gabapentin in clinical specimens like serum, plasma, and urine. These sensors are user-friendly, require minimal sample preparation, and offer low detection limits, making them promising for point-of-care and field applications .
Clinical and Forensic Prevalence of Gabapentin Detection
Gabapentin is increasingly detected in clinical and forensic settings, especially among individuals with a history of opioid misuse. Studies show high prevalence rates in urine samples from emergency departments and post-mortem cases, often in combination with opioids, highlighting the importance of including gabapentin in drug screening panels. Traditional immunoassay-based urine drug screens have limited utility for gabapentin, underscoring the need for more sensitive and specific analytical methods Lee-Easton2024Riley2021.
Matrix Considerations: Urine, Blood, and Oral Fluid
Gabapentin is most frequently detected in urine, but can also be reliably identified in blood and oral fluid using mass spectrometry-based methods. While oral fluid testing is generally more sensitive for many drugs, gabapentin shows higher detection rates in urine, supporting its use as a primary matrix for screening in addiction treatment and forensic investigations .
Conclusion
A wide range of analytical methods—spanning mass spectrometry, chromatography, spectrofluorimetry, NMR, and biosensors—are available for gabapentin detection in drug screening. These methods offer high sensitivity, specificity, and adaptability for clinical, forensic, and quality control applications. The growing prevalence of gabapentin misuse, especially in combination with opioids, makes its inclusion in drug screening panels increasingly important for both public health and forensic investigations De La Vega2019Kushnir1999Lee-Easton2024+7 MORE.
Sources and full results
Most relevant research papers on this topic